US Bancorp’s St Jude Medical STJ Stock Holding History
Bought
Maintained
Sold
Other funds holding STJ
FPF
JWA
AIM
US Bancorp's STJ Position: Q1 2017 in Review
US Bancorp sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 289,250 shares — an estimated $23.2M sold.
US Bancorp first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $24.3M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.
- US Bancorp reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
- US Bancorp sold 289,250 St Jude Medical shares in Q1 2017, an estimated $23.2M.
- US Bancorp first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
- US Bancorp's St Jude Medical position peaked at $24.3M in Q2 2016.
- 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.
Based on US Bancorp's 13F filing for Q1 2017, filed 3 May 2017.